Soren Schnellhardt

Homburg, SL 66421, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Correction to: DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers.

Correction to: DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: April 24, 2026

DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers.

DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: January 27, 2026

Perioperative immune checkpoint inhibition with pembrolizumab in combination with adjuvant therapy improves event-free survival for operable locally advanced head and neck tumors

Perioperative immune checkpoint inhibition with pembrolizumab in combination with adjuvant therapy improves event-free survival for operable locally advanced head and neck tumors

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: October 24, 2025

Prognostic Significance of Macrophage Phenotypes in Peri-Tumoral Normal Tissue of Early-Stage Breast Cancer.

Prognostic Significance of Macrophage Phenotypes in Peri-Tumoral Normal Tissue of Early-Stage Breast Cancer.

Journal: Cells

Published: April 26, 2025

Head and neck squamous cell carcinoma in adults aged 45 or younger-an analysis of two tertiary cancer centres.

Head and neck squamous cell carcinoma in adults aged 45 or younger-an analysis of two tertiary cancer centres.

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: April 15, 2025

Highlights of the 2024 ASCO Annual Meeting: radiotherapy of head and neck cancer

Highlights of the 2024 ASCO Annual Meeting: radiotherapy of head and neck cancer

Journal: HNO

Published: October 24, 2024

Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes.

Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 08, 2024

Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment.

Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment.

Journal: Cancers

Published: August 19, 2024

Neutrophils in HNSCC Can Be Associated with Both a Worse or Favorable Prognosis.

Neutrophils in HNSCC Can Be Associated with Both a Worse or Favorable Prognosis.

Journal: Biomolecules

Published: December 22, 2023

A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.

A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.

Journal: International journal of radiation oncology, biology, physics

Published: July 12, 2023

Highlights of the ASCO and ESMO annual meetings 2022: radiotherapy of head and neck cancer

Highlights of the ASCO and ESMO annual meetings 2022: radiotherapy of head and neck cancer

Journal: HNO

Published: April 12, 2023

No abscopal effects of immunotherapy combined with stereotactic radiation therapy in Merkel cell carcinoma

No abscopal effects of immunotherapy combined with stereotactic radiation therapy in Merkel cell carcinoma

Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Published: March 20, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026